MOLECULIN BIOTECH INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$7.90
-9.40%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-21.6%
3 months
-7.1%
6 months
-84.3%
1 year
-96.5%
Year to date
-88.1%
52-week range
$5.26 – $259.85
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$7.7M
P/E
-0.2
P/B
0.7
P/S
—
Revenue
$0
Net income
-$30.33M
Diluted EPS
173
Gross margin
—
Net margin
—
Return on equity
-875.70%
Total debt
$147K
Cash
$7.26M
Free cash flow
-$25.36M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$7.64M | — | — | -$6.66M |
| Mar 31, 2026 | $0 | -$12.85M | — | — | -$6.11M |
| Dec 31, 2025 | $0 | $15.55M | — | — | -$5.37M |
| Sep 30, 2025 | $0 | -$25.4M | — | — | -$7.22M |
| Jun 30, 2025 | $0 | -$7.64M | — | — | -$5.58M |
| Mar 31, 2025 | $0 | -$6.44M | — | — | -$4.56M |
| Dec 31, 2024 | $0 | -$1.88M | — | — | -$5.08M |
| Sep 30, 2024 | $0 | -$10.59M | — | — | -$6.11M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MBRX news
All market newsNo ticker-linked stories are in the current archive.